Oak Street Health, Inc.
OSHDelisted May 2, 2023- Industry
- Services-Health Services
- SEC CIK
- 0001564406
Oak Street Health, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on May 4, 2023; 273 institutions reported holding it in 13F filings for Q1 2023, worth $8.37B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oak Street Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oak Street Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wassong David | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Yadav Ravi | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Partners LP | Director, 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight GP LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Harbour Point SPV LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| General Atlantic, L.P. | Director, 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments III, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments IV, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments CDA, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Genpar, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 93, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 100, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (OSH) Interholdco, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (SPV) GP, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments V, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Kusserow Paul B. K. | Director | 0 | May 2, 2023 | 0 |
| Dorsey Cheryl | Director | 0 | May 2, 2023 | 0 |
| Klapstein Julie D | Director | 0 | May 2, 2023 | 0 |
| Benjamin Regina M. | Director | 0 | May 2, 2023 | 0 |
| Kaushal Mohit | Director | 0 | May 2, 2023 | 0 |
| Pykosz Michael T | Chief Executive Officer | 0Indirect | May 2, 2023 | 0 |
| Price Geoffrey M | Chief Innovation Officer | 0Indirect | May 2, 2023 | 0 |
| Guenthner Robert | Chief Legal Officer | 0 | May 2, 2023 | 0 |
| Myers Griffin | Chief Medical Officer | 0Indirect | May 2, 2023 | 0 |
| Cook Timothy M | Chief Financial Officer | 0Indirect | May 2, 2023 | 0 |
| Keck Kim | Director | 0 | May 2, 2023 | 0 |
| Clem Brian | Chief Operating Officer | 0 | May 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $64.02 | −$3.20M | −0.6%7.77M after | 2 lots |
| Jul 30, 2021 (view filing) | Jul 29 | 1 day | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −5.90K | $62.89 | −$371.1K | −1.2%500.1K after | 2 lots |
| Jul 29, 2021 (view filing) | Jul 22 | 7 daysLate | Cook Timothy MChief Financial Officer | SSaleCommon Stock, $0.001 par value | −22.5K | $60.75 | −$1.37M | −1.7%1.34M after | 3 lots |
| Jul 29, 2021 (view filing) | Jul 28 | 1 day | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −66.4K | $61.67 | −$4.09M | −0.8%7.82M after | 2 lots |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Price Geoffrey MChief Operating Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $59.98 | −$3.00M | −1.8%2.71M after | 2 lots |
| Jul 26, 2021 (view filing) | Jul 22-23 | 4 days | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −18.6K | $61.09 | −$1.14M | −0.2%7.88M after | 2 lots |
| Jul 22, 2021 (view filing) | Jul 20 | 2 days | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −185.0K | $57.63 | −$10.7M | −2.3%7.90M after | 4 lots |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −109.4K | $55.67 | −$6.09M | −1.9%5.67M after | 3 lots |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −5.90K | $55.70 | −$328.7K | −1.2%506.0K after | 6 lots |
| Jul 14, 2021 (view filing) | Jul 13 | 1 day | Price Geoffrey MChief Operating Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $57.78 | −$2.89M | −1.8%2.76M after | 2 lots |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Clem BrianPresident, Clinical Operations | SSaleCommon Stock, $0.001 par value | −10.0K | $58.40 | −$584.0K | −1.6%597.8K after | 2 lots |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −5.90K | $58.39 | −$344.6K | −1.1%511.9K after | 4 lots |